The Ultimate Fighting Championship on Tuesday was notified that Brock Lesnar‘s UFC 200 fight-night drug test was positive for the same substance as his June 28 out-of-competition drug test.
Though the nature of the potential violation of the June 28 drug test was not initially disclosed, UFC officials confirmed that it was a substance and not a method in Tuesday’s statement. The initial positive was from a sample was collected on June 28, 2016, but the United States Anti-Doping Agency did not receive the test results from the World Anti-Doping Agency accredited UCLA Olympic Analytical Laboratory until the evening of Thursday, July 14.
The timing being what it was, Lesnar fought at UFC 200 on July 9, where he defeated Mark Hunt via unanimous decision in the night’s co-main event in Las Vegas.
In Tuesday’s statement, UFC officials announced that Lesnar also failed his in-compeitition drug test stemming from July 9.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016,” read the statement.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
RELATED > WWE Releases Statement Regarding Brock Lesnar’s Potential Anti-Doping Violation
“Consistent with all previous potential ….View full article